BioCardia
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. BioCardia's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 65% to $477,000. The net income raised on -$11,571,000 and profit margin reached -2426%. Total operating expenses were $12,121,000.

Profit Margin

BioCardia, Inc. (NASDAQ:BCDAW): Profit margin
2014 427K 234K 54.8%
2015 517K 322K 62.28%
2016 576K -10.31M -1789.93%
2017 479K -12.30M -2569.52%
2018 625K -13.87M -2219.52%
2019 710K -14.81M -2087.18%
2020 145K -15.00M -10348.28%
2021 1.01M -12.62M -1243.45%
2022 1.35M -11.91M -881.14%
2023 477K -11.57M -2425.79%

BCDAW Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
477K1.35M1.01M145K710K625K479K576K517K427K
Cost of revenue
7.72M11.90M640K4K358K517K690K746K00
Gross profit
-7.24M-10.54M375K141K352K108K-211K-170K517K427K
Operating exp.
Research and development
7.72M8.83M8.55M9.80M8.56M8.45M5.79M3.33M00
Selling and marketing
0000002.66M000
Total operating expenses
12.12M13.25M13.64M15.67M14.56M14.21M12.19M7.43M198K196K
Operating income
-11.64M-11.90M-12.63M-15.52M-14.21M-14.10M-12.40M-7.60M319K231K
Other income (expenses), net
73K-6K7K525K-496K115K97K-966K3K3K
Income before tax
-11.57M-11.90M-12.62M-15.00M-14.70M-13.98M-12.30M-10.31M322K234K
Income tax expense
06K-2K1K110K-115K-192K5.40M-6K-6K
Net income
-11.57M-11.91M-12.62M-15.00M-14.81M-13.87M-12.30M-10.31M322K234K
Earnings per share
Basic EPS
-8.19-0.67-0.75-22.24-2.63-3.25-43.54-11.0927.8620.5
Diluted EPS
-8.19-0.67-0.75-22.24-2.63-3.25-43.54-11.0927.8620.5
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source